MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16933

  1. 1,896 Posts.
    lightbulb Created with Sketch. 490
    Well... the FDA just said they feel a single arm is likely sufficient for GVHD... you were wrong it seems there. This stock must be "living in your head" considering you keep coming back.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.